Literature DB >> 22689705

The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.

Sook Hui Kim1, Hyun Seok Kang, Hee Jin Kim, Yeonsil Moon, Hui Jin Ryu, Min Young Kim, Seol-Heui Han.   

Abstract

Prior research has shown that the total amount of white matter ischemia had no significant correlation with cognitive deficits. We compared the association of white matter hyperintensities (WMHs) of total as well as cholinergic pathways with clinical dementia severity and investigated whether cholinergic ischemic burden had an independent predictive value with respect to cognitive decline in subcortical vascular cognitive impairment (SVCI). Forty-eight patients underwent detailed neuropsychological tests and brain magnetic resonance imaging. Quantification of WMH in the total white matter and in cholinergic pathways was achieved using the visual Scheltens scale and Cholinergic Pathway HyperIntensity Scale (CHIPS), respectively. We explored the association between WMH scores and clinical dementia rating scale (CDR). To assess the relation between WMH and cognitive scores, multiple linear regression analysis was used. The CHIPS score was higher in subcortical vascular dementia compared to subcortical vascular MCI, while this difference was not found with the total TMHs (TWMH) score. The TWMH score had a positive correlation with CHIPS, however only CHIPS scores positively correlated with sum of box scores of CDR scale (CDR SB; ρ = .474, P = .001). Higher CHIPS scores were associated with lower performance on the semantic word fluency test (β = -.447, P = .036), whereas the TWMH scores had no independent predictive value with respect to cognitive impairment, after controlling for CHIPS score. Our data confirmed the association of ischemic damage within cholinergic pathways with dementia severity, independent of TWMH in SVCI. In addition, this cholinergic deficit is clinically relevant to cognitive deterioration, especially with frontal dysfunction.

Entities:  

Mesh:

Year:  2012        PMID: 22689705     DOI: 10.1177/0891988712445089

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  15 in total

1.  Different patterns of functional and structural alterations of hippocampal sub-regions in subcortical vascular mild cognitive impairment with and without depression symptoms.

Authors:  Jinping Xu; Jianjun Wang; Hanqing Lyu; Xuejia Pu; Ziyun Xu; Yuanming Hu; Zhouke Guo; Haibo Yu; Qingmao Hu
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

2.  Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.

Authors:  Nira Cedres; Daniel Ferreira; Milan Nemy; Alejandra Machado; Joana B Pereira; Sara Shams; Lars-Olof Wahlund; Anna Zettergren; Olga Stepankova; Lenka Vyslouzilova; Maria Eriksdotter; Stefan Teipel; Michel J Grothe; Kaj Blennow; Henrik Zetterberg; Michael Schöll; Silke Kern; Ingmar Skoog; Eric Westman
Journal:  Neurology       Date:  2022-08-02       Impact factor: 11.800

3.  The Attenuating Effect of Beta-Carotene on Streptozotocin Induced Diabetic Vascular Dementia Symptoms in Rats.

Authors:  Khian Giap Lim; Rajavel Varatharajan; Arunachalam Muthuraman
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

4.  Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities.

Authors:  Dazhi Duan; Congyang Li; Lin Shen; Chun Cui; Tongsheng Shu; Jian Zheng
Journal:  Front Aging Neurosci       Date:  2016-09-07       Impact factor: 5.750

5.  Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia.

Authors:  José María García-Alberca; Silvia Mendoza; Esther Gris
Journal:  Clin Drug Investig       Date:  2022-03-28       Impact factor: 3.580

6.  Subcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory.

Authors:  Joel Ramirez; Alicia A McNeely; Christopher Jm Scott; Donald T Stuss; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2014-08-11       Impact factor: 6.982

7.  Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.

Authors:  Jan Willem van Dalen; Matthan W A Caan; Willem A van Gool; Edo Richard
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

8.  Neuroimaging criteria and cognitive performance in vascular mild cognitive impairment: A systematic review.

Authors:  Felipe Kenji Sudo; Gilberto Sousa Alves; Chan Tiel; Letice Ericeira-Valente; Denise Madeira Moreira; Jerson Laks; Eliasz Engelhardt
Journal:  Dement Neuropsychol       Date:  2015 Oct-Dec

9.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

10.  White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia.

Authors:  Qing Liu; Zude Zhu; Stefan J Teipel; Jianwei Yang; Yi Xing; Yi Tang; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2017-02-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.